Boron neutron capture therapy combined with fractionated photon irradiation for glioblastoma: A recursive partitioning analysis of BNCT patients

Authors:   K. Nakai,T. Yamamoto,H. Aiyama,T. Takada,F. Yoshida,T. Kageji,H. Kumada,T. Isobe,K. Endo,M. Matsuda,T. Tsurubuchi,Y. Shibata,S. Takano,M. Mizumoto,K. Tsuboi,A. Matsumura,
Journal: Applied Radiation and Isotopes
https://doi.org/10.1016/j.apradiso.2011.03.049
Abstract: Eight patients to received Boron Neuron Capture Therapy (BNCT) were selected from 33 newly diagnosed glioblastoma patients (NCT(+) group). Serial 42 glioblastoma patients (NCT(−) group) were treated without BNCT. The median OS of the NCT(+) group and NCT (−) group were 24.4 months and 14.9 months. In the high risk patients (RPA class V), the median OS of the NCT(+) group tended to be better than that of NCT(−) group. 50% of BNCT patients were RPA class V.